利凡诺羊膜腔穿刺配伍米非司酮米索前列醇用于中期妊娠引产的临床分析  

Clinical Observation of Rivanol Amniocentesis Combined with Mifepristone Misoprostol for Induction of Labor in the Second Trimester of Pregnancy

作　　者：唐荣 TANG Rong(Sansui County Maternal and Child Health Hospital,Sansui,Guizhou 556500)

机构地区：[1]三穗县妇幼保健院,贵州三穗556500

出　　处：《科技与健康》2023年第6期74-76,共3页Technology and Health

摘　　要：针对中期妊娠引产患者采取利凡诺羊膜腔穿刺及米索前列醇与米非司酮联合给药方式,探析其临床效果及安全性。选取2019年5月—2022年5月三穗县妇幼保健院收治的50例中期引产治疗的妊娠女性患者为研究对象,将其资料录入电脑后随机分为两组,每组25例患者。对照组患者采取单纯利凡诺羊膜腔穿刺处理措施,观察组患者在对照组基础上给予米索前列醇片阴道穹窿给药联合米非司酮口服给药,对比两组患者引产效果、引产有效率及不良反应发生率。研究发现,针对中期妊娠引产患者采用利凡诺羊膜腔穿刺及米索前列醇与米非司酮联合给药方式与单纯利凡诺羊膜腔穿刺方式相比,在长功率方面无较大差别,但在减少引产痛苦和安全性方面效果更理想,有应用推广价值。The clinical effect and safety of rivanol amniocentesis and the combination of Misoprostol and mifepristone were analyzed for the patients with induced labor in the second trimester of pregnancy.From May 2019 to May 2022,50 pregnant female patients who received mid-term induction of labor in Sansui County Maternal and Child Health Hospital were selected,and their data were entered into the computer and randomly divided into two groups,with 25 patients in each group.The patients in the control group were treated with simple rivanol amniocentesis,and the patients in the observation group were given Misoprostol vaginal fornix combined with mifepristone Oral administration on the basis of the control group.The induction effect,induction efficiency and adverse reaction rate of the two groups were compared.The study found that there was no significant difference in long power between rivanol amniocentesis and the combination of Misoprostol and mifepristone amniocentesis for the patients with induced labor in the second trimester of pregnancy,but the effect was more ideal in reducing the pain and safety of induced labor,which is worth popularizing.

关 键 词：中期妊娠引产 利凡诺羊膜腔穿刺 米索前列醇 米非司酮 

分 类 号：R719.31[医药卫生—妇产科学]